ARCHIVES

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP For The Month of February

February 24, 2012

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

ASSIST Gets Extra Year Of Funding While NCI Considers Role In Tobacco Control

January 17, 1997

Zerhouni Appoints Two Institute Directors

September 13, 2002

UICC Announces Four Fellowship Program

April 22, 1983

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000